These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15784260)

  • 21. Mouse models of sickle cell disease.
    Beuzard Y
    Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hydroxyurea, erythrocyte volumes and hemoglobin F].
    Bargetzi MJ; Schönenberger A; Tichelli A; Passweg J; Rabaglio M; Singer D; Sissolak G; Gratwohl A; Speck B
    Schweiz Med Wochenschr; 1995 Mar; 125(9):433-5. PubMed ID: 7534433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia.
    Hines P; Dover GJ; Resar LM
    Pediatr Blood Cancer; 2008 Feb; 50(2):357-9. PubMed ID: 17253639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell disease pathophysiology.
    Noguchi CT; Schechter AN; Rodgers GP
    Baillieres Clin Haematol; 1993 Mar; 6(1):57-91. PubMed ID: 8353318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hb A variant (beta73 Asp-->Leu) disrupts Hb S polymerization by a novel mechanism.
    Adachi K; Ding M; Surrey S; Rotter M; Aprelev A; Zakharov M; Weng W; Ferrone FA
    J Mol Biol; 2006 Sep; 362(3):528-38. PubMed ID: 16926024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.
    De Souza DC; Hebert N; Esrick EB; Ciuculescu MF; Archer NM; Armant M; Audureau É; Brendel C; Di Caprio G; Galactéros F; Liu D; McCabe A; Morris E; Schonbrun E; Williams D; Wood DK; Williams DA; Bartolucci P; Higgins JM
    Nat Commun; 2023 Sep; 14(1):5850. PubMed ID: 37730674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal hemoglobin in sickle cell anemia.
    Akinsheye I; Alsultan A; Solovieff N; Ngo D; Baldwin CT; Sebastiani P; Chui DH; Steinberg MH
    Blood; 2011 Jul; 118(1):19-27. PubMed ID: 21490337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of fetal haemoglobin rate (FHb) on the oxidizing stress in homozygote sickle cell patient living in Abidjan, Côte-d'Ivoire].
    Nacoulma EW; Sawadogo D; Sakandé J; Mansour A; Hien FH; Sangaré A; Sess ED
    Bull Soc Pathol Exot; 2006 Oct; 99(4):241-4. PubMed ID: 17111970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sickle Cell Hemoglobin.
    Mandal AK; Mitra A; Das R
    Subcell Biochem; 2020; 94():297-322. PubMed ID: 32189305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonideality and the nucleation of sickle hemoglobin.
    Ivanova M; Jasuja R; Kwong S; Briehl RW; Ferrone FA
    Biophys J; 2000 Aug; 79(2):1016-22. PubMed ID: 10920031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo polymerization of sickle-cell hemoglobin: a theoretical study.
    Makhijani VB; Cokelet GR
    Blood Cells; 1994; 20(1):169-83; discussion 184-90. PubMed ID: 7994059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
    Lapouméroulie C; Benkerrou M; Odièvre MH; Ducrocq R; Brun M; Elion J
    Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular polymerization. Disease severity and therapeutic predictions.
    Noguchi CT; Rodgers GP; Schechter AN
    Ann N Y Acad Sci; 1989; 565():75-82. PubMed ID: 2476066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea treatment for sickle cell disease.
    Steinberg MH
    ScientificWorldJournal; 2002 Jun; 2():1706-28. PubMed ID: 12806165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
    Fathallah H; Atweh GF
    Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of F cells in sickle cell disorders by flow cytometry -- comparison with the Kleihauer-Betke's slide method.
    Italia KY; Colah R; Mohanty D
    Int J Lab Hematol; 2007 Dec; 29(6):409-14. PubMed ID: 17988294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in sickle cell disease].
    de Montalembert M
    Bull Acad Natl Med; 2008 Oct; 192(7):1375-81; discussion 1381. PubMed ID: 19445363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Betke's and elution methods in estimation of haemoglobin F in sickle cell anaemia.
    Kotila TR; Adeyemo AA; Abbiyesuku FM; Shokunbi WA
    East Afr Med J; 2000 Jun; 77(6):336-9. PubMed ID: 12858937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hemoglobin biophysical studies on molecular pathogenesis and drug therapy for sickle cell disease.
    Eaton WA
    Mol Aspects Med; 2022 Apr; 84():100971. PubMed ID: 34274158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiological-based approaches to treatment of sickle cell disease.
    Steinberg MH; Brugnara C
    Annu Rev Med; 2003; 54():89-112. PubMed ID: 12359829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.